Free Trial
NYSEARCA:IDNA

iShares Genomics Immunology and Healthcare ETF (IDNA) Price, Holdings, & News

iShares Genomics Immunology and Healthcare ETF logo
$41.42 -2.73 (-6.18%)
Closing price 04:10 PM Eastern
Extended Trading
$41.29 -0.13 (-0.31%)
As of 05:29 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About iShares Genomics Immunology and Healthcare ETF (NYSEARCA:IDNA)

Advanced

Key Stats

Today's Range
$41.21
▼
$43.81
50-Day Range
$37.88
▼
$44.15
52-Week Range
$24.29
▼
$44.15
Volume
293,326 shs
Average Volume
76,725 shs
Market Capitalization
$325.15 million
Assets Under Management
$356.16 million
Dividend Yield
0.68%
Net Expense Ratio
0.47%
Aggregate Rating
Moderate Buy

ETF Overview

The iShares Genomics Immunology and Healthcare ETF (IDNA) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund tracks a market-cap-selected and -weighted index of global stocks involved in genomics, immunology, and bioengineering. IDNA was launched on Jun 11, 2019 and is managed by BlackRock.

iShares Genomics Immunology and Healthcare ETF Expenses

TypeIDNATheme ETFsEquity ETFsNYSEARCA ETFsAll ETFs
Management Fee0.47%0.57%0.57%0.50%0.53%
Other Expenses0.00%0.57%0.53%0.60%0.54%
Total Expense0.47%0.72%0.75%0.75%0.73%
Fee Waiver0.00%-0.72%-0.67%-0.76%-0.67%
Net Expense0.47%0.60%0.63%0.57%0.60%
Receive IDNA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for iShares Genomics Immunology and Healthcare ETF and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

IDNA ETF News Headlines

IDNA: Specialized Healthcare ETF For Tactical Bets
(IDNA) iShares Genomics Immunology and Healthcare ETF
The government is buying stocks
Donald Trump and Bernie Sanders rarely agree on anything, yet both are steering the country toward the same economic system, according to veteran analyst Porter Stansberry. The government has already taken stakes in companies like Intel, Lithium Americas, and MP Materials, while political rhetoric on both sides points toward deeper centralization. Stansberry has spent months investigating what this bipartisan shift could mean for investors navigating the months ahead.tc pixel
IDNA: 3 Catalysts To Watch Closely
iShares Genomics Immunology & Healthcare ETF
See More Headlines

IDNA ETF - Frequently Asked Questions

iShares Genomics Immunology and Healthcare ETF's stock was trading at $26.19 at the start of the year. Since then, IDNA stock has increased by 59.0% and is now trading at $41.6520.

Shares of IDNA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Fund Details

Issuer
iShares
Fund Name
iShares Genomics Immunology and Healthcare ETF
Tax Classification
Regulated Investment Company
Stock Exchange
NYSEARCA
Current Symbol
NYSEARCA:IDNA
Inception Date
6/11/2019
Fund Manager
Jennifer Hsui, Greg Savage, Paul Whitehead
Web
N/A
Phone
N/A

Fund Focus

Asset Class
Equity
Benchmark
NYSE FactSet Global Genomics and Immuno Biopharma Index
Category
Strategy
Focus
Theme
Development Level
Blended Development
Region
Global
Number of Holdings
63

Fund Statistics

Assets Under Management
$356.16 million
Average Daily Volume
$0.00
Discount/Premium
0.18%

Administrator, Advisor and Custodian

Administrator
State Street Bank and Trust Company
Advisor
BlackRock Fund Advisors
Custodian
State Street Bank and Trust Company
Distributor
BlackRock Investments, LLC
Transfer Agent
State Street Bank and Trust Company
Trustee
N/A
Lead Market Maker
Jane Street

Options

Optionable
N/A
Short Interest
67,932 shs

Miscellaneous

Beta
0.97
Creation Unit
50,000
Creation Fee
$850.00
7 Stocks to Buy Before the Robotics Revolution Cover

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report

Top 10 IDNA Holdings

IDNA Sector Exposure

IDNA Industry Exposure


This page (NYSEARCA:IDNA) was last updated on 11/5/2026 by MarketBeat.com Staff.
From Our Partners